Population
In vitro models of human and bovine activated protein C (APC)
Comparison
Mutagenesis replacing loop 148 in human protein… vs Wild-type human activated protein C and bovine APC
Design
Preclinical
Authors
Loading...
Supports engineering APC mutants with enhanced activity; leaves open clinical translation from this animal model.
Replacing loop 148 in human protein C with the shorter bovine loop enhances its catalytic and anticoagulant activity, demonstrating the potential to engineer APC mutants with increased efficacy.
Shen et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: